Teva Will Pay $315 Million For Drug Pricing Suits
This article was originally published in The Pink Sheet Daily
Executive Summary
The company reaches an agreement in principle to settle a suit claiming its drug pricing inflated government reimbursements for drugs under Medicaid.
You may also be interested in...
Cephalon's Double Trouble: DoJ Probes Treanda Marketing, Clinical Trial Data
The inquiry comes three years after the company settled a government investigation of off-label marketing of three other drugs.
Cephalon's Double Trouble: DoJ Probes Treanda Marketing, Clinical Trial Data
The inquiry comes three years after the company settled a government investigation of off-label marketing of three other drugs.
Omnicare Settlement With DoJ Shows Power Of Nursing Homes In Driving Rxs
Omnicare's settlement with the Department of Justice to resolve kickback allegations was remarkable for the breadth and complexity of the government's case. But it also cast attention on a particular segment of the pharmaceutical market: nursing homes